Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects.

about

Topiramate in Migraine Prevention: A 2016 Perspective.

P2860

Q39024628-94CA000A-9D4D-48CB-BDFB-61286B2D200C

P2860

Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects.

Item

http://www.wikidata.org/entity/Q38586750

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Modified-Release Formulations ...... okinetic and Clinical Aspects.

@en

type

Item

label

Modified-Release Formulations ...... okinetic and Clinical Aspects.

@en

prefLabel

Modified-Release Formulations ...... okinetic and Clinical Aspects.

@en

P1476

Modified-Release Formulations ...... okinetic and Clinical Aspects.

@en

P2093

Gail D Anderson

http://www.w3.org/2001/XMLSchema#string

Russell P Saneto

http://www.w3.org/2001/XMLSchema#string

P2860

Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations

Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients

Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause.

Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial

Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine

Once-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III study.

Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.

Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans.

P2888

s40263-015-0268-5

P304

669-681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40263-015-0268-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282040523

http://www.w3.org/2001/XMLSchema#string

P698

26369919

http://www.w3.org/2001/XMLSchema#string

Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects.

about

P2860

P2860

Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698